A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Small Intestine Cancer Bookmark and Share

Small Intestine Cancer

Although small intestine cancer is relatively rare in United States, it can be challenging to diagnose and treat. Thus, early detection and prompt medical care is crucial for optimal outcomes with minimal side effects.
 
City of Hope has one of the most experienced small intestine cancer programs in the United States, with a multidisciplinary team that takes an integrated approach to detecting and treating cancer of the small intestine. This includes using advanced technologies and specialized techniques such as:

  • minimally-invasive, robotically-assisted techniques for complex surgeries that can remove tumors with less discomfort, reduced risk of complications and shorter recovery times
  • highly precise radiation therapy that can target hard-to-resect tumors with minimal exposure to surrounding normal tissue
  • targeted drugs and drug combinations that can treat advanced small intestine cancer with greater effectiveness and fewer side effects, compared to traditional chemotherapy
  • combination regimens integrating surgery, radiation, chemotherapy and immunotherapy for maximum cancer-fighting effectiveness
 
Additionally, City of Hope patients have access to our extensive team of supportive care experts — including dieticians, supportive medicine physicians and rehabilitation specialists. Working closely with the patient’s primary care team, they can detect and address quality of life issues related to small intestine cancer and its treatments. This includes managing symptoms (such as pain, nausea and fatigue), adjusting to a new diet and lifestyle post-treatment (particularly if a large portion of the small intestine is removed) and being aware of possible long-term effects.
 
 
As one of a handful of institutes to attain the elite designation of Comprehensive Cancer Center by the National Cancer Institute, City of Hope is acknowledged as a leader in small intestine cancer research and treatment. With our decades of experience, specialized therapy protocols and extensive program of clinical trials, newly diagnosed or relapsed patients can find a treatment regimen that is tailored to their needs and gives them the best chance for survival. U.S. News & World Report also named City of Hope as one of the top cancer hospitals in the country.
 
 
In collaboration with other departments and cancer centers, City of Hope’s small intestine cancer program has an active portfolio of clinical trials studying novel treatments, including trials of new surgery, radiation and drug therapy regimens that are more effective against the disease and/or less harmful to the patient. Many of these promising therapies are only available to patients being treated at City of Hope.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Team

About Small Intestine Cancer

Small intestine cancer is characterized by malignant (abnormal and uncontrollably dividing) cells in the small intestine, a digestive organ responsible for absorbing nutrients from consumed food and beverages.
 
Small intestine cancer can fall into one of five types, based on the type of cells it arose from:
 
  • Adenocarcinoma, from mucus-secreting gland cells
  • Sarcoma, from muscle or connective tissue cells
  • Carcinoid tumors , from neuroendocrine cells
  • Gastrointestinal stromal tumors (GIST), from interstitial cells of Cajal, which regulate food digestion
  • Lymphoma

Signs and Symptoms of Small Intestine Cancer
 
Symptoms of small intestine cancers include:
 
  • Stools that are bloody or dark
  • Feeling discomfort, pain or fullness in the abdomen
  • Anemia
  • Unexplained weight loss
  • Fatigue and weakness
 
While many of these symptoms may be caused by other conditions, early small intestine cancer detection is crucial to successful treatment. If you or a loved one experiences any of the above symptoms, please contact a doctor for further evaluation.
 
Risk Factors of Small Intestine Cancer
 
Risk factors associated with small intestine cancer include:
 
  • Diet: A diet high in fat may elevate small intestine cancer risk, while a diet in fiber is linked with a lower risk
  • Diseases and Conditions:
    • Celiac disease: When people with celiac disease consume gluten (a protein found in wheat and several other types of grain), the body produce an immune reaction that attack intestinal tissues that can lead to cancerous changes
    • Colorectal cancer: Colorectal cancer survivors are at a higher risk for small intestine cancer
    • Genetic Conditions: Inherited gene mutations that are passed from parents to children can significantly raise small intestine cancer risk. These include familial adenomatous polyposis (FAP), hereditary non-polyposis colon cancer (HNPCC or Lynch syndrome), cystic fibrosis, Peutz-Jeghers syndrome and MUTYH-associated polyposis
    • Inflammatory Bowel Disease: Also known as Crohn’s disease or ulcerative colitis, this condition is characterized by long-term inflammation of the digestive tract, which can cause cellular changes that lead to small intestine cancer
  • Heavy alcohol use: Some studies found that excessive alcohol consumption (more than 2 drinks a day for men or 1 drink a day for women) raises small intestine cancer risk
  • Tobacco Use: Some studies link smoking to a higher small intestine cancer risk
 
If you suspect that you or a loved one may have an elevated risk of small intestine cancer, please consult with a doctor on preventive and early detection measures that are available.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

How We Diagnose and Stage Small Intestine Cancer

Diagnosing Small Intestine Cancer
 
A timely and accurate detection of small intestine cancer is essential to planning the best course of treatment. In addition to a routine physical examination and blood tests, City of Hope doctors may also use the following tests to diagnose small intestine cancer:
 
  • 3D computed tomography (CT) scan: Using advanced imaging technology and specialized techniques, radiologists at City of Hope can obtain highly precise images of the small intestine. This allows the care team to better detect and locate tumors they can be targeted with minimal impact on surrounding normal tissues.
  • Endoscopy: In this procedure, a flexible tube is inserted through the mouth and into the small intestine. A camera is attached to the tip of the tube, which can then take images of the small intestine lining. The endoscope may also be equipped with a tool to extract suspicious tissues for further evaluation.
  • Barium X-rays: Also called an upper GI series, a silver-white metallic compound is administered orally or directly in the small intestine. This compound coats the small intestine lining and allows for better visualization of abnormalities when X-rays are taken.
  • Biopsy: Abnormal-looking cells are extracted from the small intestine and checked by a pathologist for cancerous signs. Imaging tests may be used guide the biopsy to ensure accuracy.
  • Genetic testing: A genetic test of the cells extracted during biopsy can show whether the cancer is sensitive or resistant to specific treatments, so your care team can plan the most effective regimen against the disease.
 
Other tests that may be used for diagnosis or further evaluation include magnetic resonance imaging (MRI), positron emission tomography (PET) and ultrasound scans.
 
Staging Small Intestine Cancer
 
To properly plan for treatment, small cancer patients are staged in accordance to how advanced the disease is. This is primarily done by taking a number of factors into consideration, including:
 
  • Size of the tumor
  • If the tumor has grown into a blood vessel or adjacent organs, such as the stomach or colon
  • Whether the cancer has spread to nearby lymph nodes and how many lymph nodes are affected
  • Whether the cancer has metastasized to distant organs
  • If the tumor can be completely removed by surgery
 
Based on these factors, patients are staged according to their risk level, with higher risk patients typically requiring more intensive treatments.
 
More information on small intestine cancer staging criteria is available on the National Cancer Institute’s website.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Our Treatment Approach to Small Intestine Cancer

City of Hope has one of the most renowned small intestine cancer programs in the United States, with a multidisciplinary team of medical experts across different fields including surgery, radiation oncology, medical oncology and supportive care medicine. Together, they work collaboratively to plan and implement a treatment regimen that is individually tailored to the patient to improve survival chances, enhance outcomes and boost quality of life.

Surgery

Surgery is often the primary treatment for small intestine cancer, and it can be curative for early stage patients and can also improve survival outcomes and reduce discomfort for later stage patients.
 
City of Hope’s surgeons specialize in minimally invasive and robotically-assisted surgical procedures to treat small intestine cancer. By using smaller incisions compared to an open procedure, patients experience less pain, recover faster, have shorter hospital stays and are less likely to have post-surgical complications.
 
The expertise of City of Hope’s surgeons also means that they can treat small intestine cancers that are considered inoperable elsewhere. This is done through advanced procedures that can navigate around sensitive areas (such as major blood vessels) and working with radiation and medical oncologists, who may be able to shrink the tumor to down to an operable size and shape with radiation and drug therapies.
 
Surgery may also be performed to alleviate symptoms associated with small intestine cancer, such as a tumor obstructing digestive flow.
 

Radiation Therapy

Radiation can be used alone or in conjunction with other therapies to treat small intestine cancer by killing cancer cells or preventing the tumor growing larger. It is applied externally using one or more radioactive beams focused on the tumor.
 
Radiation therapy can also improve quality of life by relieving pain and stopping bleeds.
 
In addition to standard radiation regimens, City of Hope also offers Helical TomoTherapy, an advance technology combining radiation delivery with advanced imaging. This allows the radiation beams to be “sculpted” to the tumor’s size and shape, resulting in more focused radiation on the cancer site while minimizing exposure to adjacent tissues and organs.
 

Drug Therapy

City of Hope uses a wide range of chemotherapy and targeted therapy drugs to treat localized and metastatic small intestine cancer. In addition to standard drug regimens, patients have access to newly developed drugs (or drug combinations) through our clinical trials program.
 
Cancer fighting drugs can also enhance the effectiveness of surgery or radiation therapy, by shrinking the tumor before the procedure and making it easier to remove (neoadjuvant therapy), or given after the procedure to minimize the chance of recurrence (adjuvant therapy.)
 
Chemotherapy may also be given alongside radiation therapy to enhance the cancer-fighting effectiveness of both (chemoradiation.)
 
As part of the treatment team, a medical oncologist will evaluate the patient’s cancer, health and other factors, so that the chemotherapy, if appropriate, can be tailored to the patient throughout the continuum of care.
 

Become a Patient

If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Research and Clinical Trials

There is extensive collaboration between City of Hope clinicians and researchers to develop and evaluate new small intestine cancer therapies designed to improve survival and quality of life outcomes. City of Hope patients have access to a wide variety of clinical trials ranging from new chemotherapy and targeted therapies, novel surgical techniques and new radiation approaches — all focused on enhancing  treatment, detection and prevention of small intestine cancer.
 
  • Overexpression of the CEA protein in some intestinal cancers can be exploited for imaging purposes, since they will take in more of the drug M5A (which targets CEA-positive cancers) than normal tissues. Using this knowledge, researchers are investigating whether linking M5A to imaging agent 64Cu results in better visualization of tumors in a positron emission tomography (PET) scan.
  • Getting diagnosed with, and treatment for, small intestine cancer can have a profound impact on the patient’s caregivers as well. City of Hope researchers are currently studying this impact and whether a caregiver intervention program, consisting of home education and telephone support sessions, can help alleviate stress and boost quality of life.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Living with Small Intestine Cancer

While our primary goal is to cure or control the disease, another top priority is relieving suffering and discomfort for small intestine cancer patients undergoing cancer treatments.
 
In addition to curative treatments, City of Hope small intestine cancer patients and their caregivers have access to the broad range of services offered by our Department of Supportive Care Medicine. The department’s staff of professionals, including registered dieticians, rehabilitation specialists, supportive medicine physicians and clinical social workers, can help patients and loved ones with a variety of care and wellness issues including:
 
  • Managing small intestine cancer or treatment effects such as pain, nausea and fatigue
  • Palliative care to reduce discomfort and stress, physical and mental, throughout diagnosis and treatment
  • Adjusting to new dietary and lifestyle habits following small intestine cancer treatment
  • Coping and maintaining emotional/social/spiritual well-being
  • Navigating through the health care system
  • Staying healthy and active during/after treatment
  • Healing arts
  • Building caregivers’ skills  
 
The Department of Supportive Care Medicine is based in City of Hope’s Sheri & Les Biller Patient and Family Resource Center, which integrates all support services in a central location. The Biller Resource Center provides a warm and welcoming space where patients, families and caregivers can access the resources, education and support they need to strengthen and empower themselves, before, during and after treatment.
 
For more information or to contact the Biller Resource Center staff, please call 626-256-4673, ext. 32273 (3CARE).
 
 
This site includes tips, tools and online resources to help cancer patients and their families with issues that arise during cancer treatment.
 
Additional Resources

 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts more than 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Joe Komsky
Senior Development Officer
Phone: 626-218-6291
Email: jkomsky@coh.org

 
 

Small Intestine Cancer

Small Intestine Cancer

Although small intestine cancer is relatively rare in United States, it can be challenging to diagnose and treat. Thus, early detection and prompt medical care is crucial for optimal outcomes with minimal side effects.
 
City of Hope has one of the most experienced small intestine cancer programs in the United States, with a multidisciplinary team that takes an integrated approach to detecting and treating cancer of the small intestine. This includes using advanced technologies and specialized techniques such as:

  • minimally-invasive, robotically-assisted techniques for complex surgeries that can remove tumors with less discomfort, reduced risk of complications and shorter recovery times
  • highly precise radiation therapy that can target hard-to-resect tumors with minimal exposure to surrounding normal tissue
  • targeted drugs and drug combinations that can treat advanced small intestine cancer with greater effectiveness and fewer side effects, compared to traditional chemotherapy
  • combination regimens integrating surgery, radiation, chemotherapy and immunotherapy for maximum cancer-fighting effectiveness
 
Additionally, City of Hope patients have access to our extensive team of supportive care experts — including dieticians, supportive medicine physicians and rehabilitation specialists. Working closely with the patient’s primary care team, they can detect and address quality of life issues related to small intestine cancer and its treatments. This includes managing symptoms (such as pain, nausea and fatigue), adjusting to a new diet and lifestyle post-treatment (particularly if a large portion of the small intestine is removed) and being aware of possible long-term effects.
 
 
As one of a handful of institutes to attain the elite designation of Comprehensive Cancer Center by the National Cancer Institute, City of Hope is acknowledged as a leader in small intestine cancer research and treatment. With our decades of experience, specialized therapy protocols and extensive program of clinical trials, newly diagnosed or relapsed patients can find a treatment regimen that is tailored to their needs and gives them the best chance for survival. U.S. News & World Report also named City of Hope as one of the top cancer hospitals in the country.
 
 
In collaboration with other departments and cancer centers, City of Hope’s small intestine cancer program has an active portfolio of clinical trials studying novel treatments, including trials of new surgery, radiation and drug therapy regimens that are more effective against the disease and/or less harmful to the patient. Many of these promising therapies are only available to patients being treated at City of Hope.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Team

Small Intestine Cancer Team

About Small Intestine Cancer

About Small Intestine Cancer

Small intestine cancer is characterized by malignant (abnormal and uncontrollably dividing) cells in the small intestine, a digestive organ responsible for absorbing nutrients from consumed food and beverages.
 
Small intestine cancer can fall into one of five types, based on the type of cells it arose from:
 
  • Adenocarcinoma, from mucus-secreting gland cells
  • Sarcoma, from muscle or connective tissue cells
  • Carcinoid tumors , from neuroendocrine cells
  • Gastrointestinal stromal tumors (GIST), from interstitial cells of Cajal, which regulate food digestion
  • Lymphoma

Signs and Symptoms of Small Intestine Cancer
 
Symptoms of small intestine cancers include:
 
  • Stools that are bloody or dark
  • Feeling discomfort, pain or fullness in the abdomen
  • Anemia
  • Unexplained weight loss
  • Fatigue and weakness
 
While many of these symptoms may be caused by other conditions, early small intestine cancer detection is crucial to successful treatment. If you or a loved one experiences any of the above symptoms, please contact a doctor for further evaluation.
 
Risk Factors of Small Intestine Cancer
 
Risk factors associated with small intestine cancer include:
 
  • Diet: A diet high in fat may elevate small intestine cancer risk, while a diet in fiber is linked with a lower risk
  • Diseases and Conditions:
    • Celiac disease: When people with celiac disease consume gluten (a protein found in wheat and several other types of grain), the body produce an immune reaction that attack intestinal tissues that can lead to cancerous changes
    • Colorectal cancer: Colorectal cancer survivors are at a higher risk for small intestine cancer
    • Genetic Conditions: Inherited gene mutations that are passed from parents to children can significantly raise small intestine cancer risk. These include familial adenomatous polyposis (FAP), hereditary non-polyposis colon cancer (HNPCC or Lynch syndrome), cystic fibrosis, Peutz-Jeghers syndrome and MUTYH-associated polyposis
    • Inflammatory Bowel Disease: Also known as Crohn’s disease or ulcerative colitis, this condition is characterized by long-term inflammation of the digestive tract, which can cause cellular changes that lead to small intestine cancer
  • Heavy alcohol use: Some studies found that excessive alcohol consumption (more than 2 drinks a day for men or 1 drink a day for women) raises small intestine cancer risk
  • Tobacco Use: Some studies link smoking to a higher small intestine cancer risk
 
If you suspect that you or a loved one may have an elevated risk of small intestine cancer, please consult with a doctor on preventive and early detection measures that are available.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Diagnosing Small Intestine Cancer

How We Diagnose and Stage Small Intestine Cancer

Diagnosing Small Intestine Cancer
 
A timely and accurate detection of small intestine cancer is essential to planning the best course of treatment. In addition to a routine physical examination and blood tests, City of Hope doctors may also use the following tests to diagnose small intestine cancer:
 
  • 3D computed tomography (CT) scan: Using advanced imaging technology and specialized techniques, radiologists at City of Hope can obtain highly precise images of the small intestine. This allows the care team to better detect and locate tumors they can be targeted with minimal impact on surrounding normal tissues.
  • Endoscopy: In this procedure, a flexible tube is inserted through the mouth and into the small intestine. A camera is attached to the tip of the tube, which can then take images of the small intestine lining. The endoscope may also be equipped with a tool to extract suspicious tissues for further evaluation.
  • Barium X-rays: Also called an upper GI series, a silver-white metallic compound is administered orally or directly in the small intestine. This compound coats the small intestine lining and allows for better visualization of abnormalities when X-rays are taken.
  • Biopsy: Abnormal-looking cells are extracted from the small intestine and checked by a pathologist for cancerous signs. Imaging tests may be used guide the biopsy to ensure accuracy.
  • Genetic testing: A genetic test of the cells extracted during biopsy can show whether the cancer is sensitive or resistant to specific treatments, so your care team can plan the most effective regimen against the disease.
 
Other tests that may be used for diagnosis or further evaluation include magnetic resonance imaging (MRI), positron emission tomography (PET) and ultrasound scans.
 
Staging Small Intestine Cancer
 
To properly plan for treatment, small cancer patients are staged in accordance to how advanced the disease is. This is primarily done by taking a number of factors into consideration, including:
 
  • Size of the tumor
  • If the tumor has grown into a blood vessel or adjacent organs, such as the stomach or colon
  • Whether the cancer has spread to nearby lymph nodes and how many lymph nodes are affected
  • Whether the cancer has metastasized to distant organs
  • If the tumor can be completely removed by surgery
 
Based on these factors, patients are staged according to their risk level, with higher risk patients typically requiring more intensive treatments.
 
More information on small intestine cancer staging criteria is available on the National Cancer Institute’s website.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Treatment Options

Our Treatment Approach to Small Intestine Cancer

City of Hope has one of the most renowned small intestine cancer programs in the United States, with a multidisciplinary team of medical experts across different fields including surgery, radiation oncology, medical oncology and supportive care medicine. Together, they work collaboratively to plan and implement a treatment regimen that is individually tailored to the patient to improve survival chances, enhance outcomes and boost quality of life.

Surgery

Surgery is often the primary treatment for small intestine cancer, and it can be curative for early stage patients and can also improve survival outcomes and reduce discomfort for later stage patients.
 
City of Hope’s surgeons specialize in minimally invasive and robotically-assisted surgical procedures to treat small intestine cancer. By using smaller incisions compared to an open procedure, patients experience less pain, recover faster, have shorter hospital stays and are less likely to have post-surgical complications.
 
The expertise of City of Hope’s surgeons also means that they can treat small intestine cancers that are considered inoperable elsewhere. This is done through advanced procedures that can navigate around sensitive areas (such as major blood vessels) and working with radiation and medical oncologists, who may be able to shrink the tumor to down to an operable size and shape with radiation and drug therapies.
 
Surgery may also be performed to alleviate symptoms associated with small intestine cancer, such as a tumor obstructing digestive flow.
 

Radiation Therapy

Radiation can be used alone or in conjunction with other therapies to treat small intestine cancer by killing cancer cells or preventing the tumor growing larger. It is applied externally using one or more radioactive beams focused on the tumor.
 
Radiation therapy can also improve quality of life by relieving pain and stopping bleeds.
 
In addition to standard radiation regimens, City of Hope also offers Helical TomoTherapy, an advance technology combining radiation delivery with advanced imaging. This allows the radiation beams to be “sculpted” to the tumor’s size and shape, resulting in more focused radiation on the cancer site while minimizing exposure to adjacent tissues and organs.
 

Drug Therapy

City of Hope uses a wide range of chemotherapy and targeted therapy drugs to treat localized and metastatic small intestine cancer. In addition to standard drug regimens, patients have access to newly developed drugs (or drug combinations) through our clinical trials program.
 
Cancer fighting drugs can also enhance the effectiveness of surgery or radiation therapy, by shrinking the tumor before the procedure and making it easier to remove (neoadjuvant therapy), or given after the procedure to minimize the chance of recurrence (adjuvant therapy.)
 
Chemotherapy may also be given alongside radiation therapy to enhance the cancer-fighting effectiveness of both (chemoradiation.)
 
As part of the treatment team, a medical oncologist will evaluate the patient’s cancer, health and other factors, so that the chemotherapy, if appropriate, can be tailored to the patient throughout the continuum of care.
 

Become a Patient

If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Research

Small Intestine Cancer Research and Clinical Trials

There is extensive collaboration between City of Hope clinicians and researchers to develop and evaluate new small intestine cancer therapies designed to improve survival and quality of life outcomes. City of Hope patients have access to a wide variety of clinical trials ranging from new chemotherapy and targeted therapies, novel surgical techniques and new radiation approaches — all focused on enhancing  treatment, detection and prevention of small intestine cancer.
 
  • Overexpression of the CEA protein in some intestinal cancers can be exploited for imaging purposes, since they will take in more of the drug M5A (which targets CEA-positive cancers) than normal tissues. Using this knowledge, researchers are investigating whether linking M5A to imaging agent 64Cu results in better visualization of tumors in a positron emission tomography (PET) scan.
  • Getting diagnosed with, and treatment for, small intestine cancer can have a profound impact on the patient’s caregivers as well. City of Hope researchers are currently studying this impact and whether a caregiver intervention program, consisting of home education and telephone support sessions, can help alleviate stress and boost quality of life.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Living with Small Intestine Cancer

Living with Small Intestine Cancer

While our primary goal is to cure or control the disease, another top priority is relieving suffering and discomfort for small intestine cancer patients undergoing cancer treatments.
 
In addition to curative treatments, City of Hope small intestine cancer patients and their caregivers have access to the broad range of services offered by our Department of Supportive Care Medicine. The department’s staff of professionals, including registered dieticians, rehabilitation specialists, supportive medicine physicians and clinical social workers, can help patients and loved ones with a variety of care and wellness issues including:
 
  • Managing small intestine cancer or treatment effects such as pain, nausea and fatigue
  • Palliative care to reduce discomfort and stress, physical and mental, throughout diagnosis and treatment
  • Adjusting to new dietary and lifestyle habits following small intestine cancer treatment
  • Coping and maintaining emotional/social/spiritual well-being
  • Navigating through the health care system
  • Staying healthy and active during/after treatment
  • Healing arts
  • Building caregivers’ skills  
 
The Department of Supportive Care Medicine is based in City of Hope’s Sheri & Les Biller Patient and Family Resource Center, which integrates all support services in a central location. The Biller Resource Center provides a warm and welcoming space where patients, families and caregivers can access the resources, education and support they need to strengthen and empower themselves, before, during and after treatment.
 
For more information or to contact the Biller Resource Center staff, please call 626-256-4673, ext. 32273 (3CARE).
 
 
This site includes tips, tools and online resources to help cancer patients and their families with issues that arise during cancer treatment.
 
Additional Resources

 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Support This Program

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts more than 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Joe Komsky
Senior Development Officer
Phone: 626-218-6291
Email: jkomsky@coh.org

 
 
Quick Links
With Cancer, Expertise Matters

 
Cancer patients need to have confidence in their treatment plans by exploring all possible options. Often that means they should get a second opinion. For these four patients, getting a second opinion from experts at City of Hope was life-saving.
Supportive Care Calendar
 
With MyCityofHope your health information is right at your fingertips, anywhere, any time.


NEWS & UPDATES
  • Internship programs are a rite of summer for many high-achieving students. For five Caltech pre-med students, each hoping to make a mark in medicine, that rite led them to the City of Hope campus in Duarte, California, for an exceptional learning experience. The collaboration between the two high-profile resear...
  • Urinary tract stones are hard masses, or calculi, that form in the urinary tract and may cause pain, bleeding or an infection, or even block of the flow of urine. Urinary tract stones begin to form in a kidney and may enlarge in a ureter or the bladder. Depending on where a stone is located, […]
  • Every summer, hospitals nationwide experience a shortage of blood donations. This summer is no exception. Nearly 1.7 million new cancer cases are expected to be diagnosed in the U.S. this year,  and many of those patients will need blood transfusions during their treatment. Patients at City of Hope alone rely o...
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...